Biocompatible polymer-modified gold nanocomposites of different shapes as radiation sensitizers
Source abstract
Abstract
Radiation therapy is a powerful approach for cancer treatment due to its low invasiveness. The development of radiation sensitizers is of great importance as they assist in providing radiation therapy at a low dose. In this study, poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC)-modified gold nanocomposites of different shapes were created using the grafting-to approach to serve as a novel radiation sensitizer with high cellular uptake. The effect of the shape of the nanocomposite on cellular uptake by the breast cancer cell line MCF-7 was also investigated. The PMPC-modified gold nanostars showed the highest cellular uptake compared to the other gold nanocomposites (spheres and rods), whereas cell cytotoxicity was negligible among all candidates. Furthermore, the therapeutic effect of radiation of PMPC-modified nanostars was the highest among all the gold nanocomposites. These results clearly indicate that the shape of the gold nanocomposite is an important parameter for cellular uptake and radiation sensitizing effects in breast cancer cells.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Radiation Therapy and Dosimetry · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Graduate School of Engineering, Kobe University, Nada-ku, Kobe 657-8501, Japan
Graduate School of Engineering, Osaka Prefecture University, 1-1, Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan
Graduate School of Science, Technology and Innovation, Kobe University, Nada-ku, Kobe 657-8501, Japan
Center for Advanced Medical Engineering Research & Development (CAMED), Kobe University, Chuo-ku, Kobe 650-0047, Japan
Funding
Japan Society for the Promotion of Science · Foundation for Biomedical Research and Innovation
References (43)
Show source-provided references
1. Liu · Int. J. Radiat. Biol. · 2020 · 96 · 132910.1080/09553002.2020.1807641 ↗
2. Lockney · Adv. Radiat. Oncol. · 2020 · 5 · 80910.1016/j.adro.2020.06.001 ↗
3. Shah · Semin. Oncol. · 2020 · 47 · 20910.1053/j.seminoncol.2020.05.003 ↗
4. Yegya-Raman · Gynecol. Oncol. · 2020 · 159 · 57310.1016/j.ygyno.2020.08.010 ↗
5. Yoshimura · Transl. Cancer Res. · 2020 · 9 · 510810.21037/tcr.2020.02.54 ↗
6. Chithrani · Radiat. Res. · 2010 · 173 · 71910.1667/RR1984.1 ↗
7. Ashton · Theranostics · 2018 · 8 · 178210.7150/thno.22621 ↗
8. Chen · RSC Adv. · 2015 · 51 · 4051410.1039/C5RA04013B ↗
9. P.Dongre , Gold Nanoparticle-Assisted Radiation Therapy , 2017 , pp. 145–158
10. Hauser · Biomaterials · 2016 · 105 · 12710.1016/j.biomaterials.2016.07.032 ↗
11. Klein · J. Phys. Chem. B · 2014 · 118 · 615910.1021/jp5026224 ↗
12. Yang · Int. J. Mol. Sci. · 2020 · 21 · 161910.3390/ijms21051619 ↗
13. Habiba · Sci., Rep. · 2019 · 9 · 1712010.1038/s41598-019-53706-0 ↗
14. Jiang · J. Nanosci. Nanotechnol. · 2012 · 12 · 827610.1166/jnn.2012.6626 ↗
15. Nakayama · Cancer Res. · 2015 · 75 · 333710.1158/1538-7445.AM2015-3337 ↗
16. Nakayama · Radiat. Oncol. · 2016 · 11 · 9110.1186/s13014-016-0666-y ↗
17. Hainfeld · J. Pharm. Pharmacol. · 2008 · 60 · 97710.1211/jpp.60.8.0005 ↗
18. Kwatra · Transl. Cancer Res. · 2013 · 2 · 330
19. Chithrani · Nano Lett. · 2006 · 6 · 66210.1021/nl052396o ↗
20. Li · Nanoscale · 2016 · 8 · 799210.1039/C5NR08808A ↗
21. Brust · J. Chem. Soc., Chem. Commun. · 1994 · 7 · 80110.1039/C39940000801 ↗
22. Daniel · Chem. Rev. · 2004 · 104 · 29310.1021/cr030698+ ↗
23. Sun · Science · 2002 · 298 · 217610.1126/science.1077229 ↗
24. Kitayama · Anal. Chem. · 2014 · 86 · 558710.1021/ac501322x ↗
25. Kitayama · Langmuir · 2014 · 30 · 1268410.1021/la502801t ↗
26. Yoshida · ACS Appl. Bio Mater. · 2019 · 2 · 117710.1021/acsabm.8b00766 ↗
27. Huang · J. Am. Chem. Soc. · 2006 · 128 · 211510.1021/ja057254a ↗
28. Nikoobakht · Chem. Mater. · 2003 · 15 · 195710.1021/cm020732l ↗
29. Pérez-Juste · Chem. Rev. · 2005 · 249 · 1870
30. Barbosa · Langmuir · 2010 · 26 · 1494310.1021/la102559e ↗
31. Hao · Nano Lett. · 2007 · 7 · 72910.1021/nl062969c ↗
32. Kumar · Nanotechnology · 2008 · 19 · 01560610.1088/0957-4484/19/01/015606 ↗
33. Zhang · Biomaterials · 2012 · 33 · 640810.1016/j.biomaterials.2012.05.047 ↗
34. Ma · ACS Appl. Mater. Interfaces · 2017 · 9 · 1303710.1021/acsami.7b01112 ↗
35. Soenen · Part. Part. Syst. Charact. · 2014 · 31 · 79410.1002/ppsc.201300357 ↗
36. Arnida · J. Appl. Toxicol. · 2010 · 30 · 21210.1002/jat.1486 ↗
37. Jackson · ACS Nano · 2017 · 11 · 568010.1021/acsnano.7b01110 ↗
38. Feng · Biointerphases · 2006 · 1 · 5010.1116/1.2187495 ↗
39. Ishihara · J. Biomed. Mater. Res. · 1998 · 39 · 32310.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C ↗
40. Colley · Mol. Pharm. · 2014 · 11 · 117610.1021/mp400610b ↗
41. Liang · Oncogenesis · 2018 · 7 · 9810.1038/s41389-018-0107-x ↗
42. Sato · Life Sci. · 2009 · 85 · 80010.1016/j.lfs.2009.10.012 ↗
43. Rahman · Nanomedicine · 2009 · 5 · 13610.1016/j.nano.2009.01.014 ↗